Preference for Easyhaler® Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study

被引:3
|
作者
Javier Alvarez-Gutierrez, Francisco [1 ]
Gomez-Bastero Fernandez, Ana [2 ]
Medina Gallardo, Juan Francisco [1 ]
Campo Sien, Carlos [3 ]
Rytila, Paula [4 ]
Delgado Romero, Julio [5 ]
机构
[1] Hosp Univ Virgen del Rocio, Unidad Asma, Av Manuel Siurot S-N, Seville 41013, Spain
[2] Hosp Univ Virgen Macarena, Unidad Asma, Seville, Spain
[3] Orion Pharma Iberia, Madrid, Spain
[4] Orion Pharma Corp, Espoo, Finland
[5] Hosp Virgen Macarena, Unidad Gest Clin Alergol, Seville, Spain
来源
关键词
patient satisfaction; adherence; inhaler devices; dry powder inhalers; asthma control; clinical outcomes; ADHERENCE; SATISFACTION; COPD;
D O I
10.2147/PPA.S295710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To study patient preference for and satisfaction with the Easyhaler (R) device and to assess ease of training and use of the inhaler in patients previously treated with a variety of dry powder inhalers (DPIs). Methods: We designed a non-interventional, cross-sectional, single-visit observational study of adult patients with persistent asthma referred to specialized care who had previously been treated with DPI inhalers for at least 3 months. Once clinical baseline data had been checked, patients filled in questionnaires on asthma control (GINA 2019), Feeling of Satisfaction with the Inhaler (FSI-10), and adherence (TAI and Morisky-Green questionnaires). Thereafter, all patients were trained in the use of Easyhaler. We assessed ease of use and satisfaction (FSI-10) with Easyhaler, as well as inhaler device preferences. Results: We recruited 502 patients (mean age, 50.2 +/- 16.2 y; 63.1% female), of whom 485 were evaluable. In response to the main objective of the study, we compared the values of the self-completed adapted FSI-10, to measure satisfaction with the inhaler. A significantly higher score in each item of the questionnaire was recorded for Easyhaler. Overall, 38% of patients showed exclusive preference for Easyhaler (compared with 15% for the previous device) or were evenly matched in 46% of cases. Conclusion: In the present study, Easyhaler achieved better patient ratings in terms of preference and satisfaction than previously used DPI devices. In order to improve asthma adherence strategies, patient preferences and device choice should be taken into account.
引用
收藏
页码:349 / 358
页数:10
相关论文
共 50 条
  • [41] A randomized, comparative study of formoterol and terbutaline dry powder inhalers in the treatment of mild to moderate asthma exacerbations in the pediatric acute care setting
    Bussamra, Maria H.
    Stelmach, Rafael
    Rodrigues, Joaquim C.
    Cukier, Alberto
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (03) : 248 - 253
  • [42] A 6-month safety and efficacy study of fluticasone propionate and fluticasone propionate/salmeterol multidose dry powder inhalers in persistent asthma
    Mansfield, Lyndon
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    ALLERGY AND ASTHMA PROCEEDINGS, 2017, 38 (04) : 264 - 276
  • [43] Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
    Schuster, Antje
    Haliburn, Cynthia
    Doering, Gerd
    Goldman, Martin Harris
    THORAX, 2013, 68 (04) : 344 - 350
  • [44] Safety of albuterol sulfate (AS) via spiros™ dry powder inhaler (DPI) compared to albuterol (A) via ventolin™ metered dose inhaler (MDI) and to placebo over 12 weeks in patients with asthma.
    Kemp, J
    Nelson, H
    Bieler, S
    Vaughan, L
    Hill, M
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S7 - S7
  • [45] Asthma control and COPD symptom burden: results from a multi-country observational study (SPRINT) in patients using fixed dose combination (FDC) inhalers
    Roche, Nicolas
    Plaza, Vicente
    Backer, Vibeke
    Van der Palen, Job
    Cerveri, Isa
    Gonzalez, Chelo
    Safioti, Guilherme
    Scheepstra, Irma
    Patino, Oliver
    Singh, Dave
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [46] The effects of salmeterol/fluticasone combination (SFC) dry powder inhaler (DPI) on asthma control and quality of life, in patients previously treated with inhaled corticosteroids (ICS)
    McCarthy, TP
    Edin, HM
    House, K
    Yan, SK
    Vandermeer, AK
    THORAX, 2001, 56 : 63 - 64
  • [47] Inhalation devices for long-acting β2-agonists:: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD
    Molimard, Mathieu
    Till, Denise
    Stenglein, Stephan
    Singh, Dilraj
    Krummen, Markus
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (10) : 2405 - 2413
  • [48] Once-daily treatment with mometasone furoate dry powder inhaler (MF-DPI) provides effective asthma control in inhaled corticosteroid-dependent patients with moderate asthma
    Karpel, Jill P.
    D'Urzo, Anthony
    Yao, Ruji
    CHEST, 2007, 132 (04) : 510S - 511S
  • [49] Comparing Usability of NEXThaler® with Other Inhaled Corticosteroid/Long-Acting β2-Agonist Fixed Combination Dry Powder Inhalers in Asthma Patients
    Voshaar, Thomas
    Spinola, Monica
    Linnane, Patrick
    Campanini, Alice
    Lock, Daniel
    Lafratta, Anthony
    Scuri, Mario
    Ronca, Barbara
    Melani, Andrea S.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2014, 27 (05) : 363 - 370
  • [50] Comparative Analysis of Peak Inspiratory Flow Rate at Discharge and Three-month Follow-up in Severe Acute Exacerbation of COPD Patients using Metered Dose Inhalers versus Dry Powder Inhalers: A Prospective Observational Study
    Fernandes, Lalita
    Siva, Manu
    Lawande, Durga
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (08) : OC18 - OC21